Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment
James R. Kintzing, Maria V. Filsinger Interrante, Jennifer R. Cochran
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 12, pp. 993-1008
Open Access | Times Cited: 173

Showing 26-50 of 173 citing articles:

Protein aggregation: in silico algorithms and applications
R. Prabakaran, Puneet Rawat, A. Mary Thangakani, et al.
Biophysical Reviews (2021) Vol. 13, Iss. 1, pp. 71-89
Open Access | Times Cited: 49
Directing evolution of novel ligands by mRNA display
Golnaz Kamalinia, Brian J. Grindel, Terry T. Takahashi, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 16, pp. 9055-9103
Open Access | Times Cited: 46
mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies
Oleksandra Chabanovska, Anne-Marie Galow, Robert David, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114002-114002
Open Access | Times Cited: 44
Hypervalent Iodine‐Mediated Late‐Stage Peptide and Protein Functionalization
Emmanuelle M. D. Allouche, Elija Grinhagena, Jérôme Waser
Angewandte Chemie International Edition (2021) Vol. 61, Iss. 7
Open Access | Times Cited: 44
Evolving strategies and application of proteins and peptide therapeutics in cancer treatment
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114832-114832
Open Access | Times Cited: 15
Recent progress in functionalized and targeted polymersomes and chimeric polymeric nanotheranostic platforms for cancer therapy
M H Miran Beygi, Fatemeh Oroojalian, Seyed Samad Hosseini, et al.
Progress in Materials Science (2023) Vol. 140, pp. 101209-101209
Closed Access | Times Cited: 15
Engineered therapeutic proteins for sustained-release drug delivery systems
Thoa Thi Kim Nguyen, Khang‐Yen Pham, Simmyung Yook
Acta Biomaterialia (2023) Vol. 171, pp. 131-154
Open Access | Times Cited: 14
Next generation of multispecific antibody engineering
Dániel Kéri, Matt Walker, Isha Singh, et al.
Antibody Therapeutics (2023) Vol. 7, Iss. 1, pp. 37-52
Open Access | Times Cited: 14
Therapeutic Peptides, Proteins and their Nanostructures for Drug Delivery and Precision Medicine
Ha Ram Kim, Boghos Taslakjian, Sarah Kim, et al.
ChemBioChem (2024) Vol. 25, Iss. 8
Open Access | Times Cited: 4
Current and future trends in reversed-phase liquid chromatography-mass spectrometry of therapeutic proteins
Valentina D’Atri, Amarande Murisier, Szabolcs Fekete, et al.
TrAC Trends in Analytical Chemistry (2020) Vol. 130, pp. 115962-115962
Open Access | Times Cited: 42
Towards a simple on-line coupling of ion exchange chromatography and native mass spectrometry for the detailed characterization of monoclonal antibodies
Amarande Murisier, Bastiaan L. Duivelshof, Szabolcs Fekete, et al.
Journal of Chromatography A (2021) Vol. 1655, pp. 462499-462499
Open Access | Times Cited: 35
Genetic and Covalent Protein Modification Strategies to Facilitate Intracellular Delivery
Justin M. Horn, Allie C. Obermeyer
Biomacromolecules (2021) Vol. 22, Iss. 12, pp. 4883-4904
Open Access | Times Cited: 34
Systemic delivery of proteins using novel peptides via the sublingual route
Jiamin Wu, Natalie Jones, Lukas Hohenwarter, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 290-302
Closed Access | Times Cited: 3
Innovative Formulation Platform: Paving the Way for Superior Protein Therapeutics with Enhanced Efficacy and Broadened Applications
Zheng Cao, Chaoyong Liu, Jing Wen, et al.
Advanced Materials (2024) Vol. 36, Iss. 41
Open Access | Times Cited: 3
Polymer-mediated protein/peptide therapeutic stabilization: Current progress and future directions
P S Rajalakshmi, Katherine Snell, Grace E. Kunkel, et al.
Progress in Polymer Science (2024) Vol. 156, pp. 101867-101867
Closed Access | Times Cited: 3
Plasma-Generated OH Radical Production for Analyzing Three-Dimensional Structure in Protein Therapeutics
Benjamin B. Minkoff, Joshua M. Blatz, Faraz A. Choudhury, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 47
Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications
Julio A. Camarero
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 23, pp. 5089-5099
Open Access | Times Cited: 46
Selective CXCR4+ Cancer Cell Targeting and Potent Antineoplastic Effect by a Nanostructured Version of Recombinant Ricin
Raquel Díaz, Víctor Pallarès, Olivia Cano‐Garrido, et al.
Small (2018) Vol. 14, Iss. 26
Open Access | Times Cited: 45
A chicken bioreactor for efficient production of functional cytokines
Lissa R. Herron, Clare Pridans, Matthew L. Turnbull, et al.
BMC Biotechnology (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 39
Optoregulated Protein Release from an Engineered Living Material
Shrikrishnan Sankaran, Aránzazu del Campo
Advanced Biosystems (2018) Vol. 3, Iss. 2
Open Access | Times Cited: 38
Supramolecular Phenylalanine-Derived Hydrogels for the Sustained Release of Functional Proteins
Melissa L. Jagrosse, Pamela Agredo, Brittany L. Abraham, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 2, pp. 784-796
Open Access | Times Cited: 10
Effect of trehalose polymer regioisomers on protein stabilization
Marco S. Messina, Jeong Hoon Ko, Zhongyue Yang, et al.
Polymer Chemistry (2017) Vol. 8, Iss. 33, pp. 4781-4788
Closed Access | Times Cited: 35
Next-generation flexible formats of VNAR domains expand the drug platform's utility and developability
Obinna C. Ubah, Magdalena Buschhaus, Laura T. Ferguson, et al.
Biochemical Society Transactions (2018) Vol. 46, Iss. 6, pp. 1559-1565
Closed Access | Times Cited: 35
Targeting ligand–receptor interactions for development of cancer therapeutics
Jun Woo Kim, Jennifer R. Cochran
Current Opinion in Chemical Biology (2017) Vol. 38, pp. 62-69
Closed Access | Times Cited: 34
Functionalized exosome harboring bioactive molecules for cancer therapy
Yoon Kyoung Kim, Yoonjeong Choi, Gi‐Hoon Nam, et al.
Cancer Letters (2020) Vol. 489, pp. 155-162
Closed Access | Times Cited: 28

Scroll to top